Department of Internal Medicine, Academic Medical Centre, Amsterdam, The Netherlands.
J Thorac Cardiovasc Surg. 2013 Nov;146(5):1283-9. doi: 10.1016/j.jtcvs.2013.06.017. Epub 2013 Jul 21.
Continuous glucose monitoring could be helpful for glucose regulation in critically ill patients; however, its accuracy is uncertain and might be influenced by microcirculation. We investigated the microcirculation and its relation to the accuracy of 2 continuous glucose monitoring devices in patients after cardiac surgery.
The present prospective, observational study included 60 patients admitted for cardiac surgery. Two continuous glucose monitoring devices (Guardian Real-Time and FreeStyle Navigator) were placed before surgery. The relative absolute deviation between continuous glucose monitoring and the arterial reference glucose was calculated to assess the accuracy. Microcirculation was measured using the microvascular flow index, perfused vessel density, and proportion of perfused vessels using sublingual sidestream dark-field imaging, and tissue oxygenation using near-infrared spectroscopy. The associations were assessed using a linear mixed-effects model for repeated measures.
The median relative absolute deviation of the Navigator was 11% (interquartile range, 8%-16%) and of the Guardian was 14% (interquartile range, 11%-18%; P = .05). Tissue oxygenation significantly increased during the intensive care unit admission (maximum 91.2% [3.9] after 6 hours) and decreased thereafter, stabilizing after 20 hours. A decrease in perfused vessel density accompanied the increase in tissue oxygenation. Microcirculatory variables were not associated with sensor accuracy. A lower peripheral temperature (Navigator, b = -0.008, P = .003; Guardian, b = -0.006, P = .048), and for the Navigator, also a higher Acute Physiology and Chronic Health Evaluation IV predicted mortality (b = 0.017, P < .001) and age (b = 0.002, P = .037) were associated with decreased sensor accuracy.
The results of the present study have shown acceptable accuracy for both sensors in patients after cardiac surgery. The microcirculation was impaired to a limited extent compared with that in patients with sepsis and healthy controls. This impairment was not related to sensor accuracy but the peripheral temperature for both sensors and patient age and Acute Physiology and Chronic Health Evaluation IV predicted mortality for the Navigator were.
连续血糖监测有助于危重症患者血糖调节;然而,其准确性不确定,并且可能受到微循环的影响。我们研究了微循环及其与心脏手术后患者 2 种连续血糖监测设备准确性的关系。
本前瞻性观察性研究纳入了 60 例接受心脏手术的患者。手术前放置了 2 种连续血糖监测设备(Guardian Real-Time 和 FreeStyle Navigator)。通过计算连续血糖监测与动脉参考血糖之间的相对绝对偏差来评估准确性。使用舌下侧流暗场成像测量微循环的微血管血流指数、灌注血管密度和灌注血管比例,并使用近红外光谱测量组织氧合。使用重复测量线性混合效应模型评估相关性。
Navigator 的中位相对绝对偏差为 11%(四分位距,8%16%),Guardian 的为 14%(四分位距,11%18%;P=0.05)。入住重症监护病房期间,组织氧合显著增加(6 小时后最大为 91.2%[3.9]),此后下降,20 小时后稳定。灌注血管密度的下降伴随着组织氧合的增加。微循环变量与传感器的准确性无关。较低的外周温度(Navigator,b=-0.008,P=0.003;Guardian,b=-0.006,P=0.048),以及对于 Navigator,较高的急性生理学和慢性健康评估 IV 预测死亡率(b=0.017,P<0.001)和年龄(b=0.002,P=0.037)与传感器准确性降低有关。
本研究结果表明,心脏手术后患者使用这两种传感器的准确性均可接受。与脓毒症和健康对照患者相比,患者的微循环受损程度有限。这种损害与传感器的准确性无关,但与两种传感器的外周温度以及急性生理学和慢性健康评估 IV 预测的死亡率和 Navigator 患者的年龄有关。